Skip to main content
← Back to board (業界新聞)

One dose of gene-editing drug cut bad cholesterol 62% for months in small trial

by Ars Technica Ars Technica@mastodon.social ·
Posted in 業界新聞

One dose of gene-editing drug cut bad cholesterol 62% for months in small trial

The interim Phase I trial data was only from 35 people, but results look good so far. https://arstechnica.com/health/2026/05/one-dose-of-gene-editing-drug-cut-bad-cholesterol-62-for-months-in-small-trial/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social

One dose of gene-editing drug cut bad cholesterol 62% for months in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.

arstechnica.com
Image 1
View original 0 Likes 0 Boosts

Comments (1)